Takara Bio Inc.
Investor Relations

Investor Relations

Investor Relations

Message from the President

Message from the President

Medium/Long-Term
Management Plan

Medium/Long-Term <br>Management Plan

Latest Financial Statement

Financial Results
parts_max: 1

IR Event

2026/2/13
3Q financial results announcement for FY ending March 31, 2026

IR Calendar

Corporate Introduction

Latest report

Consolidated Financial Results for the Nine Months Ended December 31, 2025 （484KB）
　
Click here for back numbers

IR News

2026/02/13 (Summary) Notice Concerning Expression of Opinion in Support of Tender Offer for Company Shares by Takara Holdings, and Recommendation to Tender Share （254KB）
2026/02/13 Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP) （485KB）
2025/11/12 [Correction] Notice Concerning Revisions to Notice Concerning Revisions to the Financial Results Forecasts and Dividend Forecasts (No dividends) and P （161KB）
2025/11/11 Notice Concerning Revisions to the Financial Results Forecasts and Dividend Forecasts (No dividends) and Partial Return of Executive Remuneration （141KB）
2025/11/11 Consolidated Financial Results for the Six Months Ended September 30, 2025 （310KB）

Read More

Management Policy

Financial Data

IR Library

Stock Information

IR Calendar

FAQ

Contact IR

Disclosure Policy

User Guide

CLOSE
MENU

サイト内検索

footer-content

menu

JA
EN

contact

gnavi-box